Ad
related to: von willebrand in pregnancy causes and remedies treatment chart printableVisit our official site and gain access to patient resources, tools, and support.
Search results
Von Willebrand disease is a prevalent condition in females of childbearing age, and during pregnancy, it is associated with a higher risk of postpartum bleeding, exposure to massive transfusion protocols, pulmonary edema, acute renal injury, postpartum bleeding-related maternal mortality, and transfusion-related complications .
May 15, 2024 · Key points. With proper care, women with von Willebrand disease (VWD) can have a successful pregnancy and deliver a healthy child. Close monitoring throughout pregnancy is important for women with VWD. Women with VWD are at risk for serious bleeding after delivery.
People also ask
How does von Willebrand disease affect women?
Does von Willebrand disease cause bleeding events during pregnancy and childbirth?
What is von Willebrand disease (vWD)?
Does type 1 von Willebrand disease cause bleeding?
Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost . 2016;42(7):717-723. Stoof SC, van Steenbergen HW, Zwagemaker A, et al. Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.
May 1, 2017 · During pregnancy, hormonal influences lead to an increase in vWF and clotting factors VII, VIII, and X while anticoagulant factors (such as protein S) decrease, shifting hemostasis to a procoagulant state to compensate for anticipated hemorrhage during parturition. 3 Although vWF and FVIII levels rise and peak during the third trimester, women with vWD remain at risk of early pregnancy ...
- Caroline Berube, Brian Dietrich
- 2017
Jan 1, 2022 · von Willebrand disease (VWD) disproportionately affects women because of the potential for heavy menstrual bleeding (HMB), delivery complications, and postpartum hemorrhage (PPH). To systematically synthesize the evidence regarding first-line management of HMB, treatment of women requiring or desiring neuraxial analgesia, and management of PPH.
von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment. Luis D. Pacheco, MD; Maged M. Costantine, MD; George R. Saade, MD; Sara Mucowski, MD; Gary D.V. Hankins, MD; Anthony C. Sciscione, DO. von Willebrand disease is caused by either a quantitative or qualitative defect in von Willebrand factor (VWF).
